Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lindgren

Showing results (131-140 of 163) with videos related to

Pageof 17
Sort By:
Fetal Diagnosis and Therapy|May 4, 2025
Collaboration on Treatment of Twin-to-Twin Transfusion Syndrome in a Borderless Nordic CenterLone Nikoline Nørgaard, Maria Stefopoulou, Lotte Harmsen, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|December 8, 2004
The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE studyAndre Lamy, Bengt Jönsson, William S Weintraub, et al.
BMJ Open|September 24, 2020
Study for Improving Maternal Pregnancy And Child ouTcomes (IMPACT): a study protocol for a Swedish prospective multicentre cohort studyLina Bergman, Anna Sandström, Bo Jacobsson, et al.
Plos One|June 30, 2018
Sociodemographic determinants and health outcome variation in individuals with type 1 diabetes mellitus: A register-based studyCarl Willers, Hanna Iderberg, Mette Axelsen, et al.
Clinical Therapeutics|April 4, 2017
Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in SpainGuillermo Villa, Mickael Lothgren, Lucie Kutikova, et al.
Clinical and Translational Medicine|September 14, 2022
Microbial and human transcriptome in vaginal fluid at midgestation: Association with spontaneous preterm deliveryTove Wikström, Sanna Abrahamsson, Johan Bengtsson-Palme, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 16, 2020
Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in SwedenUlf Landmesser, Peter Lindgren, Emil Hagström, et al.
JIMD Reports|November 8, 2024
Disease burden among patients with Arginase 1 deficiency and their caregivers: A multinational, cross-sectional surveySara Olofsson, Sofia Löfvendahl, Julia Widén, et al.
Journal of Medical Economics|September 4, 2024
Societal costs and quality of life associated with arginase 1 deficiency in a European setting - a multinational, cross-sectional surveySara Olofsson, Sofia Löfvendahl, Julia Widén, et al.
Acta Obstetricia Et Gynecologica Scandinavica|June 12, 2026
Validity of hypertensive disorders of pregnancy diagnoses in the Swedish pregnancy register using a contemporary cohortMark Frick, Lina Bergman, Ylva Carlsson, et al.
Pageof 17

Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
Fetal Diagnosis and Therapy|May 4, 2025
Collaboration on Treatment of Twin-to-Twin Transfusion Syndrome in a Borderless Nordic CenterLone Nikoline Nørgaard, Maria Stefopoulou, Lotte Harmsen, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|December 8, 2004
The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE studyAndre Lamy, Bengt Jönsson, William S Weintraub, et al.
BMJ Open|September 24, 2020
Study for Improving Maternal Pregnancy And Child ouTcomes (IMPACT): a study protocol for a Swedish prospective multicentre cohort studyLina Bergman, Anna Sandström, Bo Jacobsson, et al.
Plos One|June 30, 2018
Sociodemographic determinants and health outcome variation in individuals with type 1 diabetes mellitus: A register-based studyCarl Willers, Hanna Iderberg, Mette Axelsen, et al.
Clinical Therapeutics|April 4, 2017
Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in SpainGuillermo Villa, Mickael Lothgren, Lucie Kutikova, et al.
Clinical and Translational Medicine|September 14, 2022
Microbial and human transcriptome in vaginal fluid at midgestation: Association with spontaneous preterm deliveryTove Wikström, Sanna Abrahamsson, Johan Bengtsson-Palme, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 16, 2020
Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in SwedenUlf Landmesser, Peter Lindgren, Emil Hagström, et al.
JIMD Reports|November 8, 2024
Disease burden among patients with Arginase 1 deficiency and their caregivers: A multinational, cross-sectional surveySara Olofsson, Sofia Löfvendahl, Julia Widén, et al.
Journal of Medical Economics|September 4, 2024
Societal costs and quality of life associated with arginase 1 deficiency in a European setting - a multinational, cross-sectional surveySara Olofsson, Sofia Löfvendahl, Julia Widén, et al.
Acta Obstetricia Et Gynecologica Scandinavica|June 12, 2026
Validity of hypertensive disorders of pregnancy diagnoses in the Swedish pregnancy register using a contemporary cohortMark Frick, Lina Bergman, Ylva Carlsson, et al.
Pageof 17